Estamos realizando la búsqueda. Por favor, espere...
1581
37
170
28872
4397
2595
347
374
Abstract: Purpose: Chemotherapy plus anti-EGFR is standard first-line therapy in RAS wt metastatic colorectal cancer (mCRC) but biomarkers of early response are clinically needed. We aimed to define the utility of ctDNA to assess early response in mCRC patients receiving first-line anti-EGFR therapy. Experimental design: Prospective multicentric study of tissue RAS wt mCRC patients treated with first-line chemotherapy plus cetuximab undergoing sequential liquid biopsies. Baseline and early (C3) ctDNA were analyzed by NGS. Trunk mutations were assessed as surrogate marker of total tumor burden. RAS/BRAF/MEK/EGFR-ECD were considered mutations of resistance. ctDNA results were correlated with clinical outcome. Results: 100 patients were included. ctDNA was detected in 72% of patients baseline and 32% at C3. Decrease in ctDNA trunk mutations correlated with progression-free survival (PFS) (HR= 0.23 P=0.001). RAS/BRAF were the only resistant mutations detected at C3. An increase in the relative fraction of RAS/BRAF at C3 was followed by an expansion of the RAS clone until PD, and was associated with shorter PFS (HR= 10.5, P<0.001). The best predictor of response was combined analysis of trunk and resistant mutations at C3. Accordingly, patients with "early molecular response" (decrease in trunk and decrease in resistant mutations) had better response (77.5% vs. 25%, P=0.008) and longer PFS (HR=0.18, P<0.001) compared to patients with "early molecular progression" (increase in trunk and/or increase in resistant mutations). Conclusions: ctDNA detects early molecular response and predicts benefit to chemotherapy plus cetuximab. A comprehensive NGS-based approach is recommended to integrate information on total disease burden and resistant mutations.
Fuente: Clinical Cancer Research, 2023, 29(2), 379-388
Editorial: American Association for Cancer Research
Fecha de publicación: 28/09/2023
Nº de páginas: 11
Tipo de publicación: Artículo de Revista
DOI: 10.1158/1078-0432.CCR-22-1696
ISSN: 1078-0432,1557-3265
Url de la publicación: https://doi.org/10.1158/1078-0432.CCR-22-1696
Leer publicación
VIDAL, JOANA
FERNÁNDEZ-RODRÍGUEZ, MARÍA CONCEPCIÓN
CASADEVALL, DAVID
GARCÍA-ALFONSO, PILAR
PÁEZ, DAVID
GUIX, MARTA
ALONSO, VICENTE
CANO, MARÍA TERESA
SANTOS, CRISTINA
DURÁN, GEMA
ÉLEZ, ELENA
MANZANO, JOSÉ LUIS
GARCÍA-CARBONERO, ROCÍO
FERREIRO-MONTEAGUDO, REYES
LOSA, FERRÁN
PINEDA, ESTELA
SASTRE, JAVIER
FERNANDO RIVERA HERRERO
BELLOSILLO, BEATRIZ
TABERNERO, JOSEP
Volver